Toggle light / dark theme

A Silver Bullet Against the Brain-Eating Amoeba?

The brain-eating monsters are real enough — they lurk in freshwater ponds in much of the United States. Now scientists may have discovered a new way to kill them.

Minuscule silver particles coated with anti-seizure drugs one day may be adapted to halt Naegleria fowleri, an exceptionally lethal microbe that invades through the sinuses and feeds on human brain tissue.

The research, published in the journal Chemical Neuroscience, showed that repurposing seizure medicines and binding them to silver might kill the amoebae while sparing human cells. Scientists hope the findings will lay an early foundation for a quick cure.

Team finds how error and reward signals are organized within the cerebral cortex

Psychiatrists diagnose people with schizophrenia, ADHD, bipolar disorder and other mental illnesses by spending time with them, looking for the particular behavior symptoms of each. What follows can be a hit-or-miss series of medications and dosages until disruptive behaviors go away.

By deciphering the circuitry of the medial frontal cortex — an area beneath the top of the head — those diagnoses could become much more efficient and precise by allowing physicians to diagnose based on how neurons respond to a simple series of behavior tests.

A Vanderbilt University team recently described how error and reward signals are organized within the cerebral cortex, which is only as thick as a nickel. They say this information could also be significant in drug development by guiding medications to target receptors in particular layers of the cerebral cortex where they will be most effective.

This year we will start discovering more new biological molecules

2019 will be the year in which we discover molecules and properties that are as yet unknown to humans. The breadth of biology and the enormous flexibility of genetic material will provide us with an ideal platform to explore an effectively unlimited number of molecules for novel materials and solutions. We will ultimately leave behind hydrocarbons and truly enter the biological age.

Joshua Hoffman is cofounder and CEO of Zymergen

– Meet the companies fixing depression by stimulating neurons.

Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease

In patients with Alzheimer’s disease (AD), amyloid-β (Aβ) plaques and tau protein tangles accumulate in the brain long before the appearance of clinical symptoms. Early intervention is critical for slowing neurodegeneration and disease progression. Therefore, reliable markers of early AD are needed. Lucey et al. analyzed sleep patterns in aging cognitively normal subjects and showed that non–rapid eye movement (NREM) sleep negatively correlated with tau pathology and Aβ deposition in several brain areas. The results show that alterations in NREM sleep may be an early indicator of AD pathology and suggest that noninvasive sleep analysis might be useful for monitoring patients at risk for developing AD.

In Alzheimer’s disease (AD), deposition of insoluble amyloid-β (Aβ) is followed by intracellular aggregation of tau in the neocortex and subsequent neuronal cell loss, synaptic loss, brain atrophy, and cognitive impairment. By the time even the earliest clinical symptoms are detectable, Aβ accumulation is close to reaching its peak and neocortical tau pathology is frequently already present. The period in which AD pathology is accumulating in the absence of cognitive symptoms represents a clinically relevant time window for therapeutic intervention. Sleep is increasingly recognized as a potential marker for AD pathology and future risk of cognitive impairment. Previous studies in animal models and humans have associated decreased non–rapid eye movement (NREM) sleep slow wave activity (SWA) with Aβ deposition. In this study, we analyzed cognitive performance, brain imaging, and cerebrospinal fluid (CSF) AD biomarkers in participants enrolled in longitudinal studies of aging.

Fund the Key to Autism

Dr. Ian Hale., my friend and occasional collaborator, is a renowned authority on autism and Asperger’s. He has spent a lifetime furthering our understanding of both.


Creating a research database to explore the autism spectrum and better understand neurodiversity. | Check out ‘Fund the Key to Autism’ on Indiegogo.

Doctor double act can help you live healthier for longer in their anti-ageing series for the Mail

Today in the Mail’s pullout, the twins focus on anti-ageing your brain, and show you simple strategies to give it a boost — from telling you why you’re becoming forgetful to revealing the techniques you can use to improve brain health and function.

Yes, in the ‘spouse’ seat during counselling was Xand, his identical twin and fellow telly doctor.

It’s quite a revelation that these two — both contenders for the title of TV’s sexiest doctor, surely — have a relationship that might require them even to think of counselling.

New role for brain’s support cells in controlling circadian rhythms

This new study, led by the MRC’s Laboratory of Molecular Biology (LMB) in Cambridge, used microscopic imaging to observe the detailed internal molecular clock timing of the astrocytes and neurons of the SCN. Surprisingly, this showed that although both types of cell have their own circadian clocks, they are differently regulated and were seen to be active at different times of the day. This delicate interplay was found to be critical in keeping the entire SCN clockwork ticking.


A new study has found that astrocytes, previously thought of as just supporting neurons in regulating circadian rhythms, can actually lead the tempo of the body’s internal clock and have been shown for the first time to be able to control patterns of daily behavior in mammals.

Old people can produce as many new brain cells as teenagers

By Helen Thomson

Old age may have its downsides, but losing the ability to grow new brain cells isn’t one: healthy people in their seventies seem to produce just as many new neurons as teenagers.

The discovery overturns a decades-old theory about how our brains age and could provide clues as to how we can keep our minds sharper for longer.